More information: Jan Mašek et al, Jag1 insufficiency alters liver fibrosis via T cell and hepatocyte differentiation defects ...

In unusual circumstances, Ipsen has been given the green light for its odevixibat drug for severe itching (pruritus) in patients with rare liver disease Alagille syndrome (ALGS) in the EU – for ...

He was just a day old when he was diagnosed with a genetic disease called Alagille syndrome, a condition that leads to liver failure. Orlando was placed on a transplant list as a baby, and after an ...

in patients with the rare liver disease Alagille syndrome (ALGS). Kayfanda (odevixibat) is labelled in the EU to treat cholestatic pruritus – itching caused by impaired bile formation or flow ...

Changes in certain liver tests are common in patients with Alagille syndrome and PFIC but can worsen during treatment. These changes may be a sign of liver injury. In PFIC, this can be serious or ...

Liver injury. Changes in certain liver tests are common in patients with Alagille syndrome and PFIC but can worsen during treatment. These changes may be a sign of liver injury. In PFIC ...

He was just a day old when he was diagnosed with a genetic disease called Alagille syndrome, a condition that leads to liver failure. Orlando was placed on a transplant list as a baby, and after ...

Mirum and Takeda entered into an exclusive license agreement in September 2021 for the development and commercialization of LIVMARLI for rare cholestatic pediatric liver diseases in Japan.